Shandong Sinoglory Health (603182) — Cash Flow Reinvestment Rate
Shandong Sinoglory Health (603182) has a Cash Flow Reinvestment Rate of 0.69x as of December 2025, reinvesting CN¥54.79 Million (capex CN¥54.75 Million plus investments CN¥47.63K) from operating cash flow of CN¥79.36 Million. Check Shandong Sinoglory Health earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Sinoglory Health Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Shandong Sinoglory Health across 6 annual periods. Explore Shandong Sinoglory Health cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shandong Sinoglory Health (2020–2025)
Year-by-year capital reinvestment analysis for Shandong Sinoglory Health. For live market cap and broader valuation context, see Shandong Sinoglory Health market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | CN¥54.79 Million | CN¥79.36 Million | CN¥54.75 Million | ▼ -45.9% |
| 2024 | 1.28x | CN¥400.44 Million | CN¥313.81 Million | CN¥399.54 Million | ▼ -84.4% |
| 2023 | 8.19x | CN¥305.65 Million | CN¥37.34 Million | CN¥154.79 Million | ▲ +650.5% |
| 2022 | 1.09x | CN¥119.07 Million | CN¥109.17 Million | CN¥45.29 Million | ▼ -26.1% |
| 2021 | 1.48x | CN¥63.94 Million | CN¥43.34 Million | CN¥33.70 Million | ▲ +15.1% |
| 2020 | 1.28x | CN¥140.67 Million | CN¥109.73 Million | CN¥71.10 Million | — |